GEROPHARM is a national manufacturer of biotechnological drugs that ensures drug safety in Russia. The company is engaged in the production of medicines on a full cycle. GEROPHARM consists of two factories, as well as an R&D center. Areas of specialization: endocrinology, neurology, ophthalmology, gynecology and urology. Today, GEROPHARM occupies the 1st place in the Russian insulin market (IQVIA, 2023, budget market). In October 2023, the company registered a new drug Semavik® – the first Russian analogue of Ozempik®.